Shares of OKYO Pharma Limited (NASDAQ:OKYO – Get Rating) were down 6.9% during mid-day trading on Wednesday . The company traded as low as $1.12 and last traded at $1.21. Approximately 15,664 shares traded hands during trading, a decline of 97% from the average daily volume of 617,716 shares. The stock had previously closed at $1.30.
OKYO Pharma Stock Performance
The stock’s 50-day moving average is $2.02 and its 200-day moving average is $2.15.
About OKYO Pharma
OKYO Pharma Limited, a preclinical biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead product includes OK-101 for the treatment of dry eye disease. The company is also developing OK-201, a bovine adrenal medulla, lipidated-peptide preclinical analogue candidate for the treatment of neuropathic ocular pain.
Read More
- Get a free copy of the StockNews.com research report on OKYO Pharma (OKYO)
- Should Cheesecake Factory Stock Be On Your Menu?
- Buffett Reduces Taiwan Semiconductor Stake After This Happened
- Don’t Get Bullish On The S&P 500 Because Of The CPI Report
- Shockwave Medical Gets 10% Jolt, Leads Medical Gear Makers Higher
- Proterra Inc., A Penny Stock To Put On The Watchlist
Receive News & Ratings for OKYO Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OKYO Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
